Diseases, Conditions, Syndromes

Rabies vaccine candidate begins human trials in Tanzania

The University of Oxford and the Ifakara Health Institute today announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

Immunology

Researchers recommend investments in vaccine safety

The leaders of Mayo Clinic's Vaccine Research Group are emphasizing the need for increased long-term study of vaccines and their mechanisms with future safety of patients in mind.

Vaccination

Canada approves first domestic COVID-19 vaccine

Canadian health authorities approved Thursday the first domestic COVID-19 vaccine, Quebec City-based biopharmaceutical firm Medicago and its partner GlaxoSmithKline announced.

Diseases, Conditions, Syndromes

Pandemic's 'acute phase' could end by midyear: WHO

The head of the World Health Organization said Friday the acute phase of the pandemic could end this year, if around 70 percent of the world gets vaccinated.

page 3 from 40